ReMuS Press Conference | May 28^th 2025

On the occasion of World Multiple Sclerosis Day, the ReMuS and IMPULS foundations held a traditional press conference on Wednesday May 28^th 2025 at 10.00 a.m., where the latest data from the ReMuS registry were presented and leading doctors specializing in this disease discussed, whether multiple sclerosis can be stopped or blocked before it manifests itself.

Archive

ReMuS Press Conference | May 28^th 2025

7. 5. 2025

ReMuS in America - poster at the prestigious American Academy of Neurology Congress

8. 4. 2025

Get to know the ReMuS registry

18. 9. 2024

Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry

24. 6. 2024

The 1^st Neuro-Ophthalmology Forum was successfully held in the spirit of sincere cooperation between specialists across disciplines

20. 6. 2024

Neurologists: all patients must receive high quality care | 2024 ReMuS Registry Press Conference

29. 5. 2024

Big Multiple Sclerosis Data network: an international registry research network

1. 4. 2024

The 5^th ReMuS Registry Workshop took place

3. 11. 2023

Unique concert for 10 years of the ReMuS Registry

17. 10. 2023

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

26. 9. 2023

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

15. 6. 2023

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries.

12. 6. 2023

Treatment of Multiple Sclerosis is Experiencing a Revolution | ReMuS Registry Press Conference 2023

25. 5. 2023

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

28. 3. 2023

Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers

16. 2. 2023

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

2. 7. 2022

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

18. 4. 2022

Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1,533 pregnancies in Czech Republic

28. 11. 2021

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia

24. 6. 2021

COVID-19 and multiple sclerosis under scrutiny | ReMuS 2021 registry press conference

25. 5. 2021

Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network

17. 3. 2021

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

12. 1. 2021

What data does the national registry of patients with multiple sclerosis ReMuS offer?

15. 10. 2020

Multiple Sclerosis Patient Registry ReMuS - the importance of data in chronic diseases

21. 9. 2019

Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS

3. 8. 2019

How We Have Progressed Over Five Years of the ReMuS Registry's Existence

10. 12. 2018

Multiple sclerosis registries in Europe - Updated overview

4. 10. 2018

A comparison of efficacy of subcutaneous interferon β-1a 44 μg, dimethyl fumarate and fingolimod in the real-life clinical practice – a multicenter observational study

7. 6. 2018

ReMuS - The Czech Republic National Multiple Sclerosis Patient Registry

15. 11. 2016